National trends in psychotropic medication use in young children: 1994-2009

Vilawan Chirdkiatgumchai1, Hong Xiao, Bridget K Fredstrom

  • 1Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Mail Location 4002, Cincinnati, OH 45229. tanya.froehlich@cchmc.org.

Pediatrics
|October 2, 2013
PubMed

Insights

Psychotropic medication use in very young children peaked in 2002-2005, with higher rates observed in boys, white children, and those without private insurance. Usage stabilized in later years, warranting further investigation into these trends.

Area of Science:

  • Pediatric medicine
  • Psychopharmacology
  • Public health

Background:

  • Psychotropic medication use in preschool-aged children has been a growing concern.
  • Understanding national trends and disparities is crucial for appropriate clinical practice.

Purpose of the Study:

  • To analyze national trends in psychotropic prescriptions for US children aged 2-5 years.
  • To identify sociodemographic factors associated with psychotropic use in this age group.

Main Methods:

  • Utilized data from the National Ambulatory and National Hospital Ambulatory Medical Care Surveys (1994-2009).
  • Employed multivariable logistic regression to identify predictors of psychotropic use.
  • Examined temporal trends in 4-year blocks.

Main Results:

  • Psychotropic prescription rates varied, peaking at 1.45% in 2002-2005.
  • Boys, white children, older preschoolers (4-5 years), and children lacking private insurance showed higher odds of prescription.
  • Rates stabilized between 2006-2009, not differing significantly from earlier periods.

Conclusions:

  • Psychotropic prescribing in young children exhibited a peak in 2002-2005, alongside significant sociodemographic disparities.
  • Further research is needed to understand the stabilization of use post-2005 and the reasons behind increased prescribing in specific subgroups.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...